Ernexa Therapeutics Inc. Notes Payable, Noncurrent
Ernexa Therapeutics Inc. (ERNA) had Notes Payable, Noncurrent of $1.99 million as of 2019-09-30, per its 10-Q filed 2019-11-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermNotesPayable · last filed 2020-03-19
- 2019-09-30: Notes Payable, Noncurrent $1.99M.
- 2019-06-30: Notes Payable, Noncurrent $2.23M.
- 2019-03-31: Notes Payable, Noncurrent $2.48M.
- 2018-12-31: Notes Payable, Noncurrent $2.73M.
| Period end | Notes Payable, Noncurrent |
|---|---|
| 2019-09-30 | $1.99M 10-Q · filed 2019-11-01 |
| 2019-06-30 | $2.23M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $2.48M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $2.73M 10-K · filed 2020-03-19 |
| 2018-09-30 | $2.98M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $2.51M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $2.95M 10-Q · filed 2018-05-11 |
| 2017-12-31 | $8.00K 10-K · filed 2019-03-22 |
| 2017-09-30 | $92.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $264.00K 10-Q · filed 2017-08-04 |
| 2017-03-31 | $446.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $5.12M 10-K · filed 2018-03-09 |
| 2016-09-30 | $5.07M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $5.23M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $5.47M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $6.37M 10-K · filed 2017-03-09 |
| 2015-09-30 | $5.68M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $5.10M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $2.67M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $3.14M 10-K · filed 2016-03-15 |
| 2014-09-30 | $2.64M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $2.27M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $1.22M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $962.00K 10-K · filed 2015-03-27 |
| 2012-12-31 | $29.00K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |